Schaeffer experts submitted a comment letter responding to a request for information from stakeholders about improving access to cell and gene therapies for ultra-rare diseases.
Other featured articles
Does Medicare Advantage Deliver Better Care for Persons Living with Dementia than Traditional Medicare?
With data available from CMS on all Medicare beneficiaries enrolled in private plans and traditional Medicare, researchers at the USC Schaeffer Center are driving new research on how payment structures impact the care of persons living with dementia.
The Inflation Reduction Act’s Harms Go Beyond Drug Pricing — They’re Threatening Your Medicare
The IRA threatens to deliver disaster across the entire innovation, financing and distribution system for prescription drugs.
Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?
Lack of awareness remains one of the biggest barriers to participation in Alzheimer’s disease clinical trials, especially among underrepresented groups. New ways to connect with communities and to expand access to clinical trials include a virtual Alzheimer’s disease informational series, which reveals important insights about how people engage with virtual content differently than at in-person events.
Biden’s Hepatitis C Initiative Needs Help from the Private Market
Instead of this massive nationalized program, the White House could make four administrative changes that would jump-start private-sector solutions in each state.